Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

DMT Discontinuation Review Stirs MS Research Community

Daniel Kantor
The U.S. Agency for Healthcare Research and Quality (AHRQ) recently released a draft review on the evidence on discontinuation of disease-modifying therapies. Shocked by the apparent lack of expertise in the first draft, MS researchers and advocacy groups sent in a wave of comments chastising the AHRQ for the perceived shoddiness of the report.
A draft review of the evidence surrounding discontinuation of disease-modifying therapies has sparked...
Clinical Research, Methods

Pages

Subscribe to Multiple Sclerosis Discovery Forum RSS